ChEM-H seeks to support research projects driven by junior investigators and aimed at testing molecular hypotheses in human subjects. Submissions must include an MD or MD/PhD investigator and a junior investigator.
The Innovative Medicines Accelerator (IMA) aims to accelerate the translation of scientific discoveries at into new therapeutics that impact human health. This RFP supports treatments for spinal muscular atrophy and other neuromuscular diseases.
The KL2 Mentored Career Development Program (KL2 Scholars Program) at Stanford University is a two-year research program funded by the National Institutes of Health (NIH) and the Stanford Clinical Translational Science Award (CTSA) Program.
Addressing the impact of structural racism and social injustice as key drivers in health disparities that affect maternal and child health are critical to advancing research.
The Innovative Medicines Accelerator (IMA) aims to accelerate the prototyping of innovative medicines, and to enable hypothesis-driven studies on human subjects. This RFP seeks to leverage Stanford Clinical and Translational Research Unit.
Internal funding opportunity for Stanford Medicine faculty in all lines within seven years of first faculty appoinment. Open to women pursuing advancement or to men or women who support the advancement of women in medicine and/or medical research.
This grant is to attract and increase junior faculty members, including highly qualified physicians, physician-scientists, population-based or basic/translational scientists, and to maximize their potential to be leaders in academic medicine
Grants of up to $7,500 to support new mass spectrometry projects and methodologies in emerging research areas, early phase investigations, and pilot studies.
The Spectrum SPADA Pilot Program funds projects with a goal of diagnosing and/or predicting the onset, course, worsening, or complications of disease, and prolonging health.
